Physician profile
Patrick Garvin
NPI 1801357736
$35,753.76
in general payments reported to CMS, 2019-2025
13 companies · $11K in 2025
The $11K reported for 2025 was more than what 87% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,200 · 2023: $17.15 · 2024: $24K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $26K · Travel and Lodging: $5,209 · Food and Beverage: $3,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $26,250.00 |
| Travel and Lodging | $5,209.10 |
| Food and Beverage | $3,094.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,956.97 | 2024-2025 | |
| Smith+Nephew, INC. | $7,621.43 | 2024-2025 | Healicoil, Q-Fix |
| Kairos Surgical INC | $1,954.60 | 2022-2025 | |
| Stryker Corporation | $1,871.31 | 2024-2025 | Iconix, Alphavent, Salvation |
| Encore Medical, Lp | $1,515.51 | 2025 | Djo Surgical |
| Miach Orthopaedics, INC. | $186.30 | 2025 | |
| Bodycad USA Corp | $173.35 | 2025 | Fine Osteotomy |
| Joint Restoration Foundation, INC. | $170.14 | 2025 | |
| Ossur Americas, INC. | $116.41 | 2025 | Unloader One X |
| Gemini Mountain Medical, LLC | $80.70 | 2024-2025 | |
| Vericel Corporation | $65.31 | 2025 | Maci |
| Linvatec Corporation | $25.41 | 2025 | Biobrace 23mm |
| Medacta USA, INC. | $16.32 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Garvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.